Patient Care

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on squamous cell carcinoma of the conjunctiva, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.

Jacobi Cleaver, OD, FAAO, caught up with Optometry Times to talk about his presentation on neurotrophic keratits, which he discussed at the National Optometric Association in Fort Lauderdale, Florida.

Essence Johnson, OD, FAAO, hosts an insightful conversation about the Black eye care experience at NOA 2023 Convention in Fort Lauderdale, Florida.

Take a look back at the first half of 2023 as we explore the role of AI in the eye care field in anticipation of the changes to come.

A recently completed non-human primate study of VGX-0111 demonstrated good tolerability, provided strong transgene expression in the targeted region of the retina, and increased production of the lipids whose decline is associated with macular degeneration.

Horizon Therapeutics announced the Brazilian Health Regulatory Agency (ANVISA) has approved TEPEZZA as the first and only medicine approved in Brazil for treatment of thyroid eye disease.

Jacqueline Theis, OD, FAAO, discusses photophobia and how to most effectively treat this patient population, including when and how to utilizing blue light blockers.

Maria Richman, OD, FAAO, and Harvey Richman, OD, FAAO, FCOVD, met with Optometry Times to discuss their presentations on rehabilitation of a patient who suffered from issues of vertical vision after a stroke, as well as integrating patient care with the business model.

Clark Chang, OD, MSA, MSc, FAAO, meets with Optometry Times to discuss HOA-correcting scleral lens at AOA in Washingtion, DC.

Janis Winters, OD, FAAO, shares insights from her case study that she copresented during the 2023 AOA Optometry's Meeting in Washington, DC.

Studies suggest that high glycemic load carbohydrate diets may alter the genetic influence of growth of the sclera and choroid, which ultimately can induce permanent changes in the development and progression of myopia.

Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "AMD updates: Staying current with its landscape," which he co-presented with Jay Haynie, OD, FAAO.

Carl Garbus, OD, FAAO, shares insights from his discussion that he copresented during the 2023 AOA Optometry's Meeting in Washington, DC.

Jacqueline Theis, OD, FAAO, shares insights from her AOA 2023 presentation on treating neurologic dry eye.

Mohammad Rafieetary, OD, FAAO, shares brief highlights from his 2023 AOA presentation, "Do you practice Eyechiatry? The psychology of vision loss," which he co-presented with Roya Attar, OD, MBA.

This 3-pronged approach for nutritional intervention to help maintain dry eye disease is in addition to a recommended dietary intake of daily oily fish.

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation, which covered 12 new treatments all optometrists should know about.

Narcotic analgesics have a role in primary eye care, however physicians must be aware of the responsibilities associated with narcotic use.

Jessica Haynes, OD, shares highlights from her 2023 AOA Optometry's Meeting presentation, "Application of angiography."

Graham Erickson, OD, FAAO, FCOVD, gives key takeaways of his presentation, "Sports vision grand rounds," which he presented during the 2023 AOA Optometry's Meeting in Washington, DC.

Mile Brujic, OD, FAAO, shares an overview of his AOA 2023 presentation that discussed the pharmaceutical treatment of anterior segment inflammatory conditions.

Optometrists should be aware of the consequences of digital device use beyond myopia.

The organization aims to educate viewers of dangers and safety precautions ahead of the eclipses.

Prevent Blindness is embarking on a new strategy to raise awareness and provide education to patients and professionals to work together to address and improve the mental wellbeing for those with vision impairment.

The clinic, connected with Transitions Academy, aims to address the unmet needs of more than 80 local Pathlight HOME clients who may have otherwise lacked access to eye exams and glasses.

Comanagement optimizes outcomes for patients who wear scleral lenses.

Provide better, more cohesive patient care with comanagement.

Artificial intelligence is the future of optometric disease monitoring.

Both are critical to successful treatment, but how can optometrists help?

Comfortable technologies, easier fits, and attractive features enable patients older than 45 years to stay in contact lenses.